Please assess the completion status of the following clinical trial:

Trial Title: The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women and men 18 to 85 years of age~* Glaucoma not adequately controlled (IOP \>18 mmHg on maximum tolerated topical therapy) with a single aqueous shunt (AS).~* Best-corrected visual acuity (BCVA) of hand motion (HM) or better in the study eye~Exclusion Criteria:~* Monocular~* Presence of more than one AS in the study eye~* Previous cyclodestruction in the study eye~* Presence of active iris neovascularization in the study eye~* Binocular diplopia~* Presence of scleral buckle in the study eye~* History or scleritis in either eye~* History of scleromalacia in the study eye~* Insufficient conjunctiva to cover AS in the study eye~* IOP cannot be accurately measured with Goldmann applanation, Pneumotonometry, or Tono-Pen in the study eye~* Presence of silicone oil in the study eye~* Presence of retinal detachment in the study eye~* Presence of intraocular or orbital tumor affecting the study eye~* Need for cataract extraction or concurrent procedure at the time of study treatment, except tectonic aqueous shunt revisions for both groups is allowed.~* In the opinion of the investigator, should not be enrolled in this study~* Unwilling or unable to give consent and satisfy requirements of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Second Aqueous Shunt (Type: ACTIVE_COMPARATOR): Second Aqueous Shunt~Either a Baerveldt Glaucoma Implant 350-mm2 BG101-350 or an Ahmed Model FP7 Flexible Plate must be used for all participants unless there is insufficient space, in which case a Baerveldt Glaucoma Implant 250-mm2 BG103-250 may be used.
- Transscleral Cyclophotocoagulation (Type: ACTIVE_COMPARATOR): Transscleral Diode Laser Cyclophotocoagulation

Based on this trial design, predict the completion outcome and termination type (if applicable).